| Flavones: An important scaffold for medicinal chemistry M Singh, M Kaur, O Silakari European journal of medicinal chemistry 84, 206-239, 2014 | 565 | 2014 |
| Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection M Singh, M Kaur, H Kukreja, R Chugh, O Silakari, D Singh European journal of medicinal chemistry 70, 165-188, 2013 | 398 | 2013 |
| Oxindole: A chemical prism carrying plethora of therapeutic benefits M Kaur, M Singh, N Chadha, O Silakari European Journal of Medicinal Chemistry 123, 858-894, 2016 | 258 | 2016 |
| Mechanistic insights and perspectives involved in neuroprotective action of quercetin AK Grewal, TG Singh, D Sharma, V Sharma, M Singh, MH Rahman, ... Biomedicine & Pharmacotherapy 140, 111729, 2021 | 144 | 2021 |
| Purinergic receptor P2X7: a novel target for anti-inflammatory therapy N Mehta, M Kaur, M Singh, S Chand, B Vyas, P Silakari, MS Bahia, ... Bioorganic & medicinal chemistry 22 (1), 54-88, 2014 | 110 | 2014 |
| Hybrids: a new paradigm to treat Alzheimer’s disease M Singh, M Kaur, N Chadha, O Silakari Molecular diversity 20, 271-297, 2016 | 95 | 2016 |
| Treatment of psoriasis: a comprehensive review of entire therapies H Bakshi, M Nagpal, M Singh, GA Dhingra, G Aggarwal Current drug safety 15 (2), 82-104, 2020 | 67 | 2020 |
| Inhibitors of switch kinase ‘spleen tyrosine kinase’in inflammation and immune-mediated disorders: a review M Kaur, M Singh, O Silakari European journal of medicinal chemistry 67, 434-446, 2013 | 65 | 2013 |
| Key heterocycle cores for designing multitargeting molecules O Silakari Elsevier, 2018 | 62 | 2018 |
| A comprehensive review on nutraceuticals: therapy support and formulation challenges V Puri, M Nagpal, I Singh, M Singh, GA Dhingra, K Huanbutta, D Dheer, ... Nutrients 14 (21), 4637, 2022 | 53 | 2022 |
| Mitochondrial dysfunction in Alzheimer’s disease: opportunities for drug development S Bhatia, R Rawal, P Sharma, T Singh, M Singh, V Singh Current Neuropharmacology 20 (4), 675, 2022 | 37 | 2022 |
| Reviving mitochondrial bioenergetics: a relevant approach in epilepsy S Singh, TG Singh, AK Rehni, V Sharma, M Singh, R Kaur Mitochondrion 58, 213-226, 2021 | 37 | 2021 |
| Design, synthesis and biological evaluation of novel 2-phenyl-1-benzopyran-4-one derivatives as potential poly-functional anti-Alzheimer's agents M Singh, O Silakari RSC advances 6 (110), 108411-108422, 2016 | 31 | 2016 |
| Osteoblast-n-osteoclast: making headway to osteoporosis treatment M Kaur, M Nagpal, M Singh Current Drug Targets 21 (16), 1640-1651, 2020 | 29 | 2020 |
| Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer’s disease: Design, synthesis and biological evaluations M Singh, M Kaur, N Singh, O Silakari Bioorganic & Medicinal Chemistry 25 (24), 6273-6285, 2017 | 28 | 2017 |
| Insight into the therapeutic aspects of ‘Zeta-Chain Associated Protein Kinase 70 kDa’inhibitors: A review M Kaur, M Singh, O Silakari Cellular signalling 26 (11), 2481-2492, 2014 | 20 | 2014 |
| Pyrazolones as a potential anticancer scaffold: Recent trends and future perspectives S Adhikari, M Singh, P Sharma, S Arora Journal of Applied Pharmaceutical Science 11 (1), 026-037, 2021 | 19 | 2021 |
| Design, synthesis and biological evaluation of 2-Phenyl-4H-chromen-4-one derivatives as polyfunctional compounds against Alzheimer’s disease M Singh, M Kaur, B Vyas, O Silakari Medicinal Chemistry Research 27, 520-530, 2018 | 18 | 2018 |
| Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation M Kaur, M Singh, O Silakari Future medicinal chemistry 9 (11), 1193-1211, 2017 | 18 | 2017 |
| Pharmacophore and docking-based hierarchical virtual screening for the designing of aldose reductase inhibitors: synthesis and biological evaluation B Vyas, M Singh, M Kaur, O Silakari, MS Bahia, B Singh Medicinal Chemistry Research 25, 609-626, 2016 | 18 | 2016 |
Om SilakariAssociate Professor, Punjabi UniversityVerified email at pbi.ac.in
